Literature DB >> 20671309

An update on contraindications for lung function testing.

Brendan G Cooper1.   

Abstract

Guidelines on contraindications for lung function tests have been based on expert opinion from >30 years ago. High-risk contraindications to lung function testing are associated with cardiovascular complications such as myocardial infarct, pulmonary embolism or ascending aortic aneurysm. Slightly less risky but still serious contraindications are predominantly centred on recovery from major thoracic, abdominal or head surgery. Less serious surgical procedures will present a possible risk, but the RR depends upon whether the lung function is essential or can wait until the patient's condition improves. In recent decades there have been moves towards less invasive surgical techniques, keyhole surgery and new technology such as laser surgery which minimise the amount of collateral damage to surrounding tissues. In thoracic surgery there is a shift in emphasis to quicker postsurgical mobility. Furthermore there has been little analysis of the scientific facts behind the current recommendations and contraindications. The principle absolute and relative contraindications are in need of revision, and recommended times of abstaining from lung function tests needs to be reviewed. This review aims to outline the key issues and suggests newer recommendations for contraindications for performing lung function using a risk matrix, as well as offering alternative approaches to testing patients who may be at risk of complication from testing. In general, the previous recommendation of waiting for 6 weeks after surgical procedures or medical complications before performing lung function can often now be reduced to <3 weeks with modern less invasive surgical techniques.

Entities:  

Mesh:

Year:  2010        PMID: 20671309     DOI: 10.1136/thx.2010.139881

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  27 in total

1.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

2.  A multicenter study to evaluate pulmonary function in osteogenesis imperfecta.

Authors:  Allison Tam; Shan Chen; Evan Schauer; Ingo Grafe; Venkata Bandi; Jay R Shapiro; Robert D Steiner; Peter A Smith; Michael B Bober; Tracy Hart; David Cuthbertson; Jeffrey Krischer; Mary Mullins; Peter H Byers; Robert A Sandhaus; Michaela Durigova; Francis H Glorieux; Frank Rauch; Vernon Reid Sutton; Brendan Lee; Eric T Rush; Sandesh C S Nagamani
Journal:  Clin Genet       Date:  2018-09-24       Impact factor: 4.438

3.  Spirometry in primary care.

Authors:  Allan L Coates; Brian L Graham; Robin G McFadden; Colm McParland; Dilshad Moosa; Steeve Provencher; Jeremy Road
Journal:  Can Respir J       Date:  2013 Jan-Feb       Impact factor: 2.409

4.  Evaluation of Inhaled Procaterol for Potential Assist Use in Patients with Stable Chronic Obstructive Pulmonary Disease.

Authors:  Norio Kodaka; Toru Yamagishi; Kayo Watanabe; Kumiko Kishimoto; Chihiro Nakano; Takeshi Oshio; Kumiko Niitsuma; Nagashige Shimada; Hiroto Matsuse
Journal:  Med Princ Pract       Date:  2018-05-17       Impact factor: 1.927

5.  Comparative evaluation of effects of intrapleural block with adjuvants on analgesia and pulmonary function after intercostal drainage: A pilot study.

Authors:  R N Verma; Navdeep Sethi; Sharmishtha Pathak; Vasu Vardhan
Journal:  Med J Armed Forces India       Date:  2018-05-28

6.  Noninvasive assessment for acute allograft rejection in a rat lung transplantation model.

Authors:  Ayuko Takahashi; Hiroshi Hamakawa; Hiroaki Sakai; Xiangdong Zhao; Fengshi Chen; Takuji Fujinaga; Tsuyoshi Shoji; Toru Bando; Hiromi Wada; Hiroshi Date
Journal:  Physiol Rep       Date:  2014-12-18

7.  The prevalence, burden and risk factors associated with chronic obstructive pulmonary disease in Commonwealth of Independent States (Ukraine, Kazakhstan and Azerbaijan): results of the CORE study.

Authors:  Damilya Nugmanova; Yuriy Feshchenko; Liudmyla Iashyna; Olga Gyrina; Kateryna Malynovska; Eljan Mammadbayov; Irada Akhundova; Nadezhda Nurkina; Luqman Tariq; Janina Makarova; Averyan Vasylyev
Journal:  BMC Pulm Med       Date:  2018-01-30       Impact factor: 3.317

8.  Relationship between lung function and grip strength in older hospitalized patients: a pilot study.

Authors:  Sarah J Holmes; Stephen C Allen; Helen C Roberts
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-19

9.  Validity of Questionnaire-Based Diagnosis of Chronic Obstructive Pulmonary Disease in Azar-Cohort Population.

Authors:  Delara Laghusi; Mahasti Alizadeh; Khalil Ansarin; Mohammad Asgari; Nayyereh Amini Sani
Journal:  Tanaffos       Date:  2016

10.  Ezrin, a Membrane Cytoskeleton Cross-Linker Protein, as a Marker of Epithelial Damage in Asthma.

Authors:  Man Jia; Xiaoyi Yan; Xinyu Jiang; Yunhui Wu; Jiayan Xu; Yaqi Meng; Yi Yang; Xia Shan; Xiuwedi Zhang; Shan Mao; Wei Gu; Stelios Pavlidis; Peter J Barnes; Ian M Adcock; Mao Huang; Xin Yao
Journal:  Am J Respir Crit Care Med       Date:  2019-02-15       Impact factor: 30.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.